66 related articles for article (PubMed ID: 1641820)
21. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
[TBL] [Abstract][Full Text] [Related]
22. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
23. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
24. Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial.
Gittins NS; Hunter-Blair YL; Matthews JN; Coulthard MG
Arch Dis Child; 2007 Jun; 92(6):499-501. PubMed ID: 17068072
[TBL] [Abstract][Full Text] [Related]
25. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Turpie AG; Levine MN; Hirsh J; Ginsberg JS; Cruickshank M; Jay R; Gent M
Chest; 1990 Apr; 97(4 Suppl):172S-175S. PubMed ID: 2108855
[TBL] [Abstract][Full Text] [Related]
26. Venography of the lower limbs. Pitfalls of the diagnostic standard. The ETTT Trial Investigators.
Bounameaux H; Prins TR; Schmitt HE; Schneider PA
Invest Radiol; 1992 Dec; 27(12):1009-11. PubMed ID: 1473916
[TBL] [Abstract][Full Text] [Related]
27. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance.
Meyerovitz MF; Polak JF; Goldhaber SZ
Radiology; 1992 Aug; 184(2):345-8. PubMed ID: 1620826
[TBL] [Abstract][Full Text] [Related]
28. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ; Agnelli G; Levine MN
Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
[TBL] [Abstract][Full Text] [Related]
29. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy.
Marder VJ; Soulen RL; Atichartakarn V; Budzynski AZ; Parulekar S; Kim JR; Edward N; Zahavi J; Algazy KM
J Lab Clin Med; 1977 May; 89(5):1018-29. PubMed ID: 323387
[TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
Goldhaber SZ; Meyerovitz MF; Green D; Vogelzang RL; Citrin P; Heit J; Sobel M; Wheeler HB; Plante D; Kim H
Am J Med; 1990 Mar; 88(3):235-40. PubMed ID: 2106783
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of pylethrombosis with alteplase. Description of a clinical case].
Sassoli S; Maestrini R; Occhini U; Caremani M
Minerva Gastroenterol Dietol; 1994 Dec; 40(4):219-21. PubMed ID: 7849152
[TBL] [Abstract][Full Text] [Related]
32. Healing of deep venous thrombosis: venographic findings in a randomized study comparing streptokinase and heparin.
Rösch J; Dotter CT; Seaman AJ; Porter JM; Common HH
AJR Am J Roentgenol; 1976 Oct; 127(4):553-8. PubMed ID: 970521
[TBL] [Abstract][Full Text] [Related]
33. [Long-term intraarterial infusion of heparin for treatment of deep venous thrombosis].
Rausis C; Marclay J; Dettwiler W; Rouvinez A
Helv Chir Acta; 1979 May; 46(1-2):75-9. PubMed ID: 468586
[No Abstract] [Full Text] [Related]
34. [Treatment of acute thrombophlebitis of the lower limbs with long-term intraosseous drug infusions].
Mel'nik VM
Vestn Khir Im I I Grek; 1979 Nov; 123(11):64-6. PubMed ID: 524666
[TBL] [Abstract][Full Text] [Related]
35. Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis.
Schulman S; Granqvist S; Wiman B; Lockner D
Thromb Res; 1985 Sep; 39(5):607-12. PubMed ID: 4082103
[TBL] [Abstract][Full Text] [Related]
36. Treatment of proximal deep-vein thrombosis using subcutaneously administered calcium heparin: comparison with intravenous sodium heparin.
White RH; Daschbach MM; McGahan JP; Keck K; Parsons GH; Hartling RP; Mungall D
Haemostasis; 1992; 22(3):129-37. PubMed ID: 1427457
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of 0.6 mg/kg rt-PA: optimum rt-PA dose revisited.
Mori E
Ann N Y Acad Sci; 2012 Sep; 1268():108-12. PubMed ID: 22994228
[TBL] [Abstract][Full Text] [Related]
38. How to select patients with deep vein thrombosis for tPA therapy.
Brown WD; Goldhaber SZ
Chest; 1989 May; 95(5 Suppl):276S-278S. PubMed ID: 2495911
[TBL] [Abstract][Full Text] [Related]
39. [Locoregional thrombolytic therapy of deep venous thromboses].
Rudofsky G; Timmermann J
Z Kardiol; 1993; 82 Suppl 2():61-3. PubMed ID: 8328210
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with alteplase in the management of intracardiac and major cardiac vessels thrombosis in pediatrics: a case series.
Al-Jazairi AS; Al-Gain RA; Bulbul ZR; Cherfan AJ
Ann Saudi Med; 2010; 30(3):227-32. PubMed ID: 20427940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
